Let's Talk Science. Let's Talk Medicine. The leading scientific social networking website and producer of educational virtual events and webinars.

FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based ...

CAR-T translational research demands precise, reproducible, and scalable flow cytometry workflows. Manual centrifugation and antibody preparation steps remain major sources of variability and cell ...

Flow cytometry enables researchers to label proteins of interest using fluorophore-conjugated antibodies and other fluorochromes. Much like immunohistochemistry, which produces two- or ...

When it comes to the laboratory workflow, researchers typically leverage the best attributes of multiple analytical instruments to evaluate complex cell-based assays. However, advanced flow cytometers ...

Flow cytometry is a strong analytical method that is utilized to determine, measure, and examine cells and particles in a heterogeneous mixture. The standard instrument comprises three primary ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the worldwide commercial launch of a new automated instrument, BD FACSDuet Premium Sample Preparation System. It prepares ...

FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Biosero, a developer of laboratory ...

This handbook is designed as a go-to reference for every flow cytometry user. Scientists using traditional systems will learn how routine workflows can benefit from the speed, throughput, and ...

Flow cytometry assay validation requires different analytical approaches in preclinical and clinical settings. A fit-for-purpose (FFP) strategy allows researchers to customize the validation to ...

The discovery of novel immunotherapies that specifically target and enhance the T-cell response against cancer, for example CAR-T cells, bispecific antibodies and checkpoint inhibitors, is a rapidly ...